Penumbra Inc (PEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1601
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Penumbra Inc (PEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures products for neuro and vascular markets. Its products are used for various procedures of thrombectomy and embolization for treating conditions such as acute ischemic stroke, brain aneurysm, acute limb ischemia, deep vein thrombosis, neuroarteriovenous malformation, body aneurysm and others. Its major products include neurovascular access systems, revascularization device, embolization coiling system and microcatheter among others. The company sells its products to specialist physicians, hospitals and clinics through direct sales organization in the US, Canada, Australia and most of the Europe. It also distributes its products through distributors worldwide. It has operations in the US, Brazil, Germany, Australia, Canada, Singapore, France and the UK. Penumbra is headquartered in Alameda, California, the US.

Penumbra Inc Key Recent Developments

Apr 06,2020 Penumbra provides update on COVID-19 response and impact
Nov 25,2019 Maggie Yuen appointed Chief Financial Officer of Penumbra
Nov 07,2019 Penumbra reports third quarter 2019 financial results
Aug 29,2019 Sri Kosaraju promoted to President and CFO of Penumbra

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Penumbra Inc – Key Facts
Penumbra Inc – Key Employees
Penumbra Inc – Key Employee Biographies
Penumbra Inc – Major Products and Services
Penumbra Inc – History
Penumbra Inc – Company Statement
Penumbra Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Penumbra Inc – Business Description
Product Category: Neuro Products
Overview
Performance
Product Category: Vacular Products
Overview
Product Category: Vascular Products
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other International
Performance
Geographical Segment: United States
Performance
Penumbra Inc – Corporate Strategy
Penumbra Inc – SWOT Analysis
SWOT Analysis – Overview
Penumbra Inc – Strengths
Penumbra Inc – Weaknesses
Penumbra Inc – Opportunities
Penumbra Inc – Threats
Penumbra Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Penumbra Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Penumbra Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Penumbra Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 06, 2020: Penumbra provides update on COVID-19 response and impact
Nov 25, 2019: Maggie Yuen appointed Chief Financial Officer of Penumbra
Nov 07, 2019: Penumbra reports third quarter 2019 financial results
Aug 29, 2019: Sri Kosaraju promoted to President and CFO of Penumbra
Aug 06, 2019: Penumbra reports second quarter 2019 financial results
May 07, 2019: Penumbra announces first quarter 2019 financial results
Feb 26, 2019: Penumbra announces fourth quarter and full year 2018 financial results
Jan 18, 2019: Penumbra names Janet Leeds and Surbhi Sarna to its board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Penumbra Inc, Key Facts
Penumbra Inc, Key Employees
Penumbra Inc, Key Employee Biographies
Penumbra Inc, Major Products and Services
Penumbra Inc, History
Penumbra Inc, Subsidiaries
Penumbra Inc, Key Competitors
Penumbra Inc, Ratios based on current share price
Penumbra Inc, Annual Ratios
Penumbra Inc, Annual Ratios (Cont...1)
Penumbra Inc, Annual Ratios (Cont...2)
Penumbra Inc, Interim Ratios
Penumbra Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Penumbra Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Penumbra Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Penumbra Inc, Performance Chart (2015 - 2019)
Penumbra Inc, Ratio Charts
Penumbra Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Penumbra Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Penumbra Inc (PEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exactech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …
  • Ferranti Computer Systems N.V.:戦略・SWOT・企業財務分析
    Ferranti Computer Systems N.V. - Strategy, SWOT and Corporate Finance Report Summary Ferranti Computer Systems N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Arris International Plc:企業の戦略・SWOT・財務分析
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Chugai Pharmaceutical Co Ltd (4519):製薬・医療:M&Aディール及び事業提携情報
    Summary Chugai Pharmaceutical Co Ltd (Chugai) is a subsidiary of Hoffmann-La Roche Ltd, which focuses on the research, development, manufacture, commercialization, import and export of the biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone an …
  • Zeltiq Aesthetics Inc (ZLTQ):企業の財務・戦略的SWOT分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • Innergex Renewable Energy Inc (INE)-エネルギー分野:企業M&A・提携分析
    Summary Innergex Renewable Energy Inc. (Innergex) is an electricity services company that develops, owns, and operates renewable power-generating facilities. It sells electricity that is generated from hydro, wind, and solar sources. The company sells electricity through long-term power purchase agr …
  • Hibbett Sports Inc:企業の戦略・SWOT・財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Power Machines-エネルギー分野:企業M&A・提携分析
    Summary Power Machines is a power engineering company that designs, manufactures and delivers equipment for thermal, nuclear, hydraulic and gas turbine power plants. The company offers steam, gas and hydraulic turbines, turbo-generators, hydraulic generators, blades for steam and gas turbines and ex …
  • Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析
    Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Eureka Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eureka Therapeutics Inc (Eureka Therapeutics) is a clinical stage biotechnology company which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological can …
  • McKesson Corp (MCK):医療機器:M&Aディール及び事業提携情報
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and syste …
  • Chr. Hansen Holding AS (CHR):企業の財務・戦略的SWOT分析
    Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務分析
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pharmathen Pharmaceuticals SA-製薬・医療分野:企業M&A・提携分析
    Summary Pharmathen Pharmaceuticals SA (Pharmathen) is a healthcare products provider that develops and markets generic products. The company’s products include oral antiplatelet agent, bactericidal cephalosporin antibiotic, retinoid, beta1-selective adrenergic receptor blocking agent, and others. It …
  • Innospec Inc. (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • Safe Orthopaedics SA (SAFOR):企業の製品パイプライン分析2018
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ImevaX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops novel vaccines to prevent chronic and nosocomial infections. Its lead product candidate IMX101, an immune evasion vaccine, is indicated for the treatment of Helicobacter pylori. Its pipeline products include IMA101 mucosal adj …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆